Training and Education Infrastructure to Provide "Turnkey Service" to Yield New York Medical Cannabis Patient Communities
OWC Pharmaceutical Research Corp., an Israel-based developer of cannabinoid-based therapies targeting a variety of different indications, on Monday announced that its wholly-owned subsidiary, One World Cannabis Ltd., is implementing regulation and patient-care consultancy services in New York to further advance the application and registration of medical cannabis business licenses within the existing medical cannabis program.
"Our intention is to provide support to local New York businesses which intend to dispense and manufacture medical cannabis and help shepherd certifications through the Medical Cannabis Program," said Dr. Yehuda Baruch, One World Cannabis director of research and regulatory affairs and international authority on medical cannabis programs.
In addition to helping guide certified New York-based medical cannabis businesses through the regulatory framework and operating infrastructure, One World Cannabis said it is helping to institute the creation of a medical cannabis patients' center, consisting of patient communities. The company said it is also offering training and educational modules for patients -- as well as physicians, caregivers and researchers -- to enhance the understanding of patient-focused medical cannabis programs within existing and developing U.S. markets.